Exchange Traded Concepts, LLC Biotechnology

Exchange Traded Concepts, LLC

$4.74 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ALLO Allogene Therapeutics, Inc.	$217M	$129,000 0.0% of portfolio	60,675	Q3 2024 Added 25.5%
IMRX Immuneering Corp	$50.1M	$128,000 0.0% of portfolio	58,349	Q3 2024 Reduced 22.14%
ARVN Arvinas, Inc.	$995M	$127,000 0.0% of portfolio	6,659	Q3 2024 Added 36.99%
IOVA Iovance Biotherapeutics, Inc.	$898M	$126,000 0.0% of portfolio	17,071	Q3 2024 Added 11.61%
NRIX Nurix Therapeutics, Inc.	$890M	$124,000 0.0% of portfolio	6,583	Q3 2024 Reduced 57.47%
IBRX Immunity Bio, Inc.	$1.35B	$122,000 0.0% of portfolio	47,984	Q3 2024 Added 8.41%
MRSN Mersana Therapeutics, Inc.	$72.9M	$121,000 0.0% of portfolio	85,006	Q3 2024 Added 95.78%
SNDX Syndax Pharmaceuticals Inc	$878M	$121,000 0.0% of portfolio	9,201	Q3 2024 Reduced 4.11%
CGEM Cullinan Oncology, Inc.	$466M	$120,000 0.0% of portfolio	9,891	Q3 2024 Reduced 23.04%
IDYA Ideaya Biosciences, Inc.	$1.11B	$116,000 0.0% of portfolio	4,547	Q3 2024 Reduced 6.27%
NUVL Nuvalent, Inc.	$3.68B	$116,000 0.0% of portfolio	1,493	Q3 2024 Reduced 41.91%
TYRA Tyra Biosciences, Inc.	$532M	$115,000 0.0% of portfolio	8,311	Q3 2024 Reduced 32.13%
HALO Halozyme Therapeutics, Inc.	$7.95B	$114,000 0.0% of portfolio	2,397	Q4 2024 Reduced 14.27%
ACET Adicet Bio, Inc.	$38.8M	$107,000 0.0% of portfolio	111,642	Q3 2024 Added 5.31%
ITOS I Teos Therapeutics, Inc.	$270M	$106,000 0.0% of portfolio	13,840	Q3 2024 Reduced 31.67%
LEGN Legend Biotech Corp	$5.92B	$106,000 0.0% of portfolio	3,265	Q3 2024 Reduced 0.7%
TSVT 2seventy Bio, Inc.	$87.1M	$102,000 0.0% of portfolio	34,816	Q3 2024 Reduced 36.56%
SMMT Summit Therapeutics Inc.	$4.05B	$101,000 0.0% of portfolio	5,681	Q4 2024 Reduced 12.59%
YMAB Y M Abs Therapeutics, Inc.	$264M	$100,000 0.0% of portfolio	12,872	Q3 2024 Reduced 11.16%
AUTL Autolus Therapeutics PLC	$182M	$98,000 0.0% of portfolio	41,866	Q3 2024 Added 9.81%
KROS Keros Therapeutics, Inc.	$280M	$98,000 0.0% of portfolio	6,242	Q4 2024 New
BCYC Bicycle Therapeutics PLC	$361M	$93,000 0.0% of portfolio	6,707	Q3 2024 Reduced 29.21%
IMTX Immatics N.V.	$412M	$93,000 0.0% of portfolio	13,155	Q3 2024 Reduced 27.36%
LYEL Lyell Immunopharma, Inc.	$141M	$86,000 0.0% of portfolio	135,050	Q3 2024 Added 37.34%
FHTX Foghorn Therapeutics Inc.	$198M	$85,000 0.0% of portfolio	18,085	Q3 2024 Reduced 49.65%
RLAY Relay Therapeutics, Inc.	$507M	$85,000 0.0% of portfolio	20,649	Q3 2024 Reduced 22.37%
STRO Sutro Biopharma, Inc.	$106M	$83,000 0.0% of portfolio	45,260	Q3 2024 Reduced 16.49%
BMEA Biomea Fusion, Inc.	$110M	$81,000 0.0% of portfolio	20,985	Q3 2024 Added 62.6%
PRLD Prelude Therapeutics Inc	$36.7M	$81,000 0.0% of portfolio	64,409	Q3 2024 Added 32.18%
FATE Fate Therapeutics Inc	$123M	$69,000 0.0% of portfolio	42,289	Q3 2024 Added 40.69%
KURA Kura Oncology, Inc.	$579M	$69,000 0.0% of portfolio	8,024	Q3 2024 Reduced 18.85%
RPTX Repare Therapeutics Inc.	$50.3M	$66,000 0.0% of portfolio	50,441	Q3 2024 Added 21.16%
IGMS Igm Biosciences, Inc.	$41.1M	$64,000 0.0% of portfolio	10,572	Q3 2024 Reduced 50.38%
TNGX Tango Therapeutics, Inc.	$286M	$53,000 0.0% of portfolio	17,426	Q3 2024 Reduced 27.12%
CPRX Catalyst Pharmaceuticals, Inc.	$2.35B	$44,000 0.0% of portfolio	2,139	Q4 2024 Added 6.58%
PTGX Protagonist Therapeutics, Inc	$1.9B	$39,000 0.0% of portfolio	1,025	Q4 2024 Added 6.66%
LGND Ligand Pharmaceuticals Inc	$1.94B	$8,000 0.0% of portfolio	83	Q4 2024 New
BBIO Bridge Bio Pharma, Inc.	$4.72B	$6,000 0.0% of portfolio	222	Q4 2024 New
CYTK Cytokinetics Inc	$4.03B	$6,000 0.0% of portfolio	128	Q4 2024 Reduced 20.0%
IONS Ionis Pharmaceuticals Inc	$4.46B	$6,000 0.0% of portfolio	178	Q4 2024 Reduced 8.72%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.